Fibroblast activation markers FAP, CD29, αSMA, PDPN, CD90, FSP1 and PDGFRβ expression levels were determined and compared for tumour and non-cancerous adjacent lung tissue from NSCLC patients by looking at the percentage positivity for each marker (Fig. 1b). The gene discussed is S100A4; the disease is neoplasm.